Andrew J. Einhorn - Net Worth and Insider Trading
Andrew J. Einhorn Net Worth
The estimated net worth of Andrew J. Einhorn is at least $18,536 dollars as of 2024-11-13. Andrew J. Einhorn is the CFO of PDS Biotechnology Corp and owns about 6,262 shares of PDS Biotechnology Corp (PDSB) stock worth over $18,536. Details can be seen in Andrew J. Einhorn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew J. Einhorn has not made any transactions after 2015-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew J. Einhorn
Andrew J. Einhorn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew J. Einhorn owns 5 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) , PDS Biotechnology Corp (PDSB) , and Myos Rens Technology Inc (MYOS) among others .
Click here to see the complete history of Andrew J. Einhorn’s form 4 insider trades.
Insider Ownership Summary of Andrew J. Einhorn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVLPQ | RVL Pharmaceuticals PLC | 2018-10-18 | Chief Financial Officer |
| PDSB | PDS Biotechnology Corp | 2017-03-01 | Chief Financial Officer |
| MYOS | Myos Rens Technology Inc | 2012-10-15 | Chief Financial Officer |
 | | 2012-10-15 | Chief Financial Officer |
| | 2022-08-12 | Interim CFO |
Andrew J. Einhorn Latest Holdings Summary
Andrew J. Einhorn currently owns a total of 1 stock. Andrew J. Einhorn owns 6,262 shares of PDS Biotechnology Corp (PDSB) as of October 6, 2015, with a value of $18,536.
Latest Holdings of Andrew J. Einhorn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 2015-10-06 | 6,262 | 2.96 | 18,536 |
Holding Weightings of Andrew J. Einhorn
Andrew J. Einhorn Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew J. Einhorn has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the acquisition of 2,250 shares on October 6, 2015, which cost Andrew J. Einhorn around $495,000.
Insider Trading History of Andrew J. Einhorn
- 1
Andrew J. Einhorn Trading Performance
GuruFocus tracks the stock performance after each of Andrew J. Einhorn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew J. Einhorn is -23.56%. GuruFocus also compares Andrew J. Einhorn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew J. Einhorn within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew J. Einhorn's insider trading performs compared to the benchmark.
Performance of Andrew J. Einhorn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.44 | | | | | |
| Relative Return to S&P 500(%) | -12.46 | | | | | |
Andrew J. Einhorn Ownership Network
Ownership Network List of Andrew J. Einhorn
Ownership Network Relation of Andrew J. Einhorn
Andrew J. Einhorn Owned Company Details
What does RVL Pharmaceuticals PLC do?
Who are the key executives at RVL Pharmaceuticals PLC?
Andrew J. Einhorn is the Chief Financial Officer of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .
RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary
Over the past 18 months, Andrew J. Einhorn made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Altchem Ltd , and a net sale of 17,544,196 shares made by Foundation Harsaul .
In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.
RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
RVL Pharmaceuticals PLC Insider Transactions
Andrew J. Einhorn Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew J. Einhorn. You might contact Andrew J. Einhorn via mailing address: C/o Myos Corporation, 45 Horsehill Road, Suite 106, Cedar Knolls Nj 07927.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
